Search
for
Sort by
Research 271–300 of 1000+
- LB1158 A novel more effective topical therapeutic approach for treatment of androgenetic alopecia: First in human trial results for topical ET-02
- Oral dutasteride can be considered a first‐line treatment for frontal fibrosing alopecia until high‐quality clinical trials could show better results with other therapies
- Lasers in the management of alopecia: a review of established therapies and advances in treatment
- Alopecia areata: Time for position statement to include new systemic therapeutic advances
- Effectiveness of the association of aesthetic therapeutic resources compared to the use of medicines for the treatment of male pattern androgenetic alopecia: systematic review and meta-analysis
- 1380 PPAR-γ modulation as a novel therapeutic strategy for scarring alopecia
- Androgenetic alopecia in males – characteristics and overview of therapies available in cosmetology and aesthetic medicine clinics
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Differentiating and Managing Cutaneous Lupus Erythematosus-Associated Alopecia and Patchy Alopecia Areata: Therapeutic Insights From Case Studies
- More than cosmetic: A personal perspective on alopecia areata and therapeutic restoration
- Attending persistent T cell activation in alopecia areata : A therapeutic option
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia
- (5) Topical cyclosporin A in alopecia totalis: failure of therapeutic effect due to lack of penetration
- Mesalazine in the treatment of extensive alopecia areata: A new therapeutic option?
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Autologous platelet-rich plasma as a potential therapeutic tool in androgenetic alopecia
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment
- Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future
- KRT6A derived from mesenchymal stem cells as a potential biomarker and therapeutic target for alopecia areata: insights from multi-omics analysis and experimental evidence
- Correction to “MiR‐200c‐3p as a Novel Genetic Marker and Therapeutic Tool for Alopecia Areata”
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment
- Combination use of triamcinolone acetonide and immunotherapy as a new therapeutic option in alopecia totalis
- Quercetin Nanocrystal Gel: A Novel Topical Therapeutic Strategy for Androgenetic Alopecia
- Response to Li et al.’s “Therapeutic efficacy of platelet-rich plasma combining with microneedling and topical minoxidil in refractory severe androgenic alopecia”
- Minoxidil cyclodextrin complexes and their inclusion in transfersomes for the enhancement of therapeutic effect on androgenic alopecia
- In silico Analysis of Berberine as a Potential Therapeutic Approach for Various Signalling Pathways Linked to Androgenetic Alopecia
- iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway